News & Updates
Filter by Specialty:
Empagliflozin lowers blood pressure in T2D
12 Mar 2022
Among hypertensives with type 2 diabetes (T2D), treatment with the sodium-glucose cotransporter 2 inhibitor empagliflozin produces clinically meaningful reductions in blood pressure, reports a recent study.
Empagliflozin lowers blood pressure in T2D
12 Mar 2022
Hyperbaric oxygen therapy promising for T2DM complications
10 Mar 2022
Hyperbaric oxygen therapy (HBOT) may be an effective treatment approach for several complications of type 2 diabetes mellitus (T2DM), such as nephropathy and retinopathy, a recent study has found.
Hyperbaric oxygen therapy promising for T2DM complications
10 Mar 2022
Severe hypoglycaemia raises risk of heart failure in adults with T2D
08 Mar 2022
Severe hypoglycaemia may contribute to a higher risk of incident heart failure (HF) among adults with type 2 diabetes (T2D), reports a study.
Severe hypoglycaemia raises risk of heart failure in adults with T2D
08 Mar 2022
Weight loss in T2D patients ups death risk, but lifestyle change can help
06 Mar 2022
Mortality is heightened among type 2 diabetes (T2D) patients with substantial weight loss, but such risk can be attenuated by improving lifestyle quality, suggests a recent study.